Examination Report |
1 | Additional Representation Sheet | 23 Dec 2010 |
1 | TM-1 | 23 Dec 2010 |
10 | Hearing Notice | 06 Aug 2015 |
11 | Order | 28 Sep 2015 |
12 | TM-16 | 15 Mar 2016 |
13 | Journal Copy | 22 Dec 2016 |
14 | Certificate | 03 Jan 2017 |
15 | TM-R(RENEWAL OF TRADE MARK) | 02 Aug 2021 |
16 | Note Sheet | 08 Mar 2022 |
17 | Renewal Certificate | 09 Mar 2022 |
2 | Power of Attorney | 23 Dec 2010 |
3 | Additional Representation Sheet | 23 Dec 2010 |
3 | TM-1 | 23 Dec 2010 |
4 | Power of Attorney | 31 Jan 2012 |
4 | TM-16 | 31 Jan 2012 |
5 | Power of Attorney | 31 Jan 2012 |
5 | TM-16 | 31 Jan 2012 |
6 | Reply to Exam Report (MIS-R) | 01 Nov 2013 |
7 | TM-50 | 11 Apr 2014 |
8 | Power of Attorney | 08 Oct 2014 |
8 | TM-16 | 08 Oct 2014 |
9 | Power of Attorney | 08 Oct 2014 |
9 | TM-16 | 08 Oct 2014 |
1 | O3 NOTICE | 10732579 | 5028150 | 26 Nov 2020 |
2 | RENEWAL NOTICE | 13156924 | 09 Mar 2022 |
The application for Reditux 100 mg injection was made on 23 December 2010.
The trademark applicant for Reditux 100 mg injection is DR.REDDYS LABORATORIES.
Reditux 100 mg injection is applied in class(es) 5.
Application for Reditux 100 mg injection is on Registered stage.
Application Id allotted to Reditux 100 mg injection is 2073570.
Trademark agent or attorney for the application is B. Sirisha, Advocate.
Reditux 100 mg injection filed with the Intellectual property office as a WORD.